CASI Pharmaceuticals, Inc. Earnings Per Share Diluted

Quick Answer

CASI Pharmaceuticals, Inc. reported Earnings Per Share Diluted of $2.56 (loss) per share for the year ending 2024.

  • CASI Pharmaceuticals, Inc. showed a decrease of -26.7% in Earnings Per Share Diluted from 2023 to 2024.
  • This data is from CASI Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
  • XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2020 to 2024), CASI Pharmaceuticals, Inc.'s Earnings Per Share Diluted has grown by 41.4%.
  • Historical annual values: Fiscal year 2024: $2.56 (loss) per share | Fiscal year 2023: $2.02 (loss) per share | Fiscal year 2022: $3.01 (loss) per share | Fiscal year 2021: $2.69 (loss) per share | Fiscal year 2020: $4.37 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: